Artificial Intelligence: Asset managers must embrace it or be competed away

'Inroads of robo-advice into financial planning'

clock • 2 min read

There has been some fairly disconcerting commentary on the possible impact of AI on our world, writes Andrew Herberts, head of private client investment management at Thomas Miller Investment.

But if one puts the potential destruction of humanity aside (a big if), our industry should be looking at the impact it will have on client service and our own role in that service. AI is here to stay, and may well be to the professions in the current era what the introduction of robots was to the manufacturing industry in the latter part of the 20th century. However, as was the case with robotics in the industrial evolution, we are far from displacing all human input.  AllianzGI unveils global artificial intelligence fund AI will be, and is, able to process large amounts of dat...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot